Liminatus Pharma, Inc. (LIMN) reporting calendar
Liminatus Pharma, Inc. files periodic reports with the SEC as LIMN on Nasdaq. Atlas tracks 5 filed reports for this issuer, each linked to its original EDGAR accession.
- Next window
- 6 Aug 2026 – 27 Sep 2026
- Latest report
- 10-Q
- Period ended
- 31 Mar 2026
- Filed
- 15 May 2026
- Reports on record
- 5
How this window is derived. Derived from this issuer's own filing history: 5 periods at a median 91-day cadence, filed a median 63 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.
Open LIMN market profile
Latest filing on SEC EDGAR ↗
Biological Products, (No Diagnostic Substances) reporting datesAll Nasdaq reporting dates
Filed periodic reports
| Form | Period ended | Filed | Lag | SEC accession |
|---|---|---|---|---|
| 10-Q | 31 Mar 2026 | 15 May 2026 | 45 days | 0001104659-26-062734 |
| 10-K | 31 Dec 2025 | 31 Mar 2026 | 90 days | 0001104659-26-037933 |
| 10-Q | 30 Sep 2025 | 14 Nov 2025 | 45 days | 0001104659-25-111651 |
| 10-Q | 30 Jun 2025 | 6 Oct 2025 | 98 days | 0001104659-25-096872 |
| 10-Q | 31 Mar 2025 | 2 Jun 2025 | 63 days | 0001410578-25-001388 |
Source: SEC EDGAR company submissions for CIK 0001971387. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.